Our survey results showed that more than 85% of patients on PD were regularly followed every 1 to 3 months, and almost every patient was checked for anemia (low hemoglobin) and mineral bone markers (ie, calcium, phosphorus, and parathyroid hormone), which was similarly complied according to multiple international guidelines and recommendations [18-20]. This evidence concerns the gene PTH and anemia.